mRECIST response combined with sorafenib-related adverse...

  • Main
  • 2016 / 10
  • mRECIST response combined with sorafenib-related adverse...

mRECIST response combined with sorafenib-related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib

Wang, Wenjun, Bai, Wei, Wang, Enxin, Zhao, Yan, Liu, Lei, Yang, Man, Cai, Hongwei, Xia, Dongdong, Zhang, Lei, Niu, Jing, Yin, Zhanxin, Zhang, Zhuoli, Fan, Daiming, Xia, Jielai, Han, Guohong
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.30451
Date:
October, 2016
File:
PDF, 1.30 MB
english, 2016
Conversion to is in progress
Conversion to is failed